Clinical Trial Update: Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures [Phase 1, Phase 2]

View source ↗

Summary

A pediatric brain tumor imaging trial using the Panitumumab-IRDye800 conjugate is in Phase 1/2 and actively recruiting to help visualize neoplasms during neuros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Panitumumab-IRDye800

Snippet

Sponsor: Stanford University | Conditions: Brain Tumor | Phase 1, Phase 2 | Status: RECRUITING